Top

Breast Cancer Research and Treatment

Published in:

01-05-2018 | Letter to the Editor

Detailed information about chemotherapy in breast control arm might affect cognitive sequelae compared with endocrine therapy patients

Author: Kadri Altundag

Published in: Breast Cancer Research and Treatment | Issue 1/2018

Excerpt

To the Editor, …

Underwood EA, Rochon PA, Moineddin R, Lee PE, Wu W, Pritchard KI, Tierney MC (2017) Cognitive sequelae of endocrine therapy in women treated for breast cancer: a meta-analysis. Breast Cancer Res Treat. https://doi.org/10.1007/s10549-017-4627-4 PubMed

Cerulla N, Arcusa À, Navarro JB, Garolera M, Enero C, Chico G, Fernández-Morales L (2017) Role of taxanes in chemotherapy-related cognitive impairment: a prospective longitudinal study. Breast Cancer Res Treat 164(1):179–187. https://doi.org/10.1007/s10549-017-4240-6 CrossRefPubMed

Title: Detailed information about chemotherapy in breast control arm might affect cognitive sequelae compared with endocrine therapy patients
Author: Kadri Altundag
Publication date: 01-05-2018
Publisher: Springer US
Published in: Breast Cancer Research and Treatment / Issue 1/2018
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-018-4672-7

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2018

Impact of chemotherapy relative dose intensity on cause-specific and overall survival for stage I–III breast cancer: ER+/PR+, HER2- vs. triple-negative

Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement

Identification and analysis of CHEK2 germline mutations in Chinese BRCA1/2-negative breast cancer patients

Management and outcomes of women diagnosed with primary breast lymphoma: a multi-institution experience

Reply to K. Altundag

Surveillance for cancer recurrence in long-term young breast cancer survivors randomly selected from a statewide cancer registry

Keynote webinar | Spotlight on antibody–drug conjugates in cancer